HUMMELSTOWN, Pa., March 1, 2017 /PRNewswire/ -- Prescient Medicine today announced that it has signed an exclusive agreementwith CenterPointe Hospital, a prominent psychiatric and addiction recovery hospital in St. Charles, Mo., to provide on-site management of its laboratory and four of its outpatient locations.
As part of the agreement,
Precision medicine is a new category of medicine that matches unique medical needs to a patient's genetic profile. Prescient Medicine's advanced genetic testing services can help reduce the risk of addiction and potential overdose in patients who require pain medication or other drugs during addiction recovery.
"We are excited to manage CenterPointe Hospital's laboratory and offer precision medicine testing services. This enables CenterPointe Hospital physicians to make more informed treatment decisions about a variety of patient conditions," said Keri Donaldson, M.D., CEO, Prescient Medicine.
"Outsourcing our laboratory to Prescient Medicine will allow us to focus on our patients, their mental health, and their sobriety. The advanced testing services that they offer will allow us to determine therapeutic medication levels with greater specificity and that is an enormous benefit for our patients," said Susan Mathis, CEO, CenterPointe Hospital.
About CenterPointe HospitalCenterPointe Hospital is the only free-standing psychiatric facility in the St. Louis Metro area. It offers a comprehensive continuum of care for a wide range of psychiatric disorders in adults, senior adults, and adolescents, and provides one of the area's only private adult alcohol and drug abuse treatment program. With inpatient and residential services at its St. Louis Metro-area facility in St. Charles, MO, and outpatient programs at six St. Louis Metro and Mid-Missouri locations, CenterPointe Hospital can help. To find out more, visit www.centerpointehospital.com.
About Prescient MedicinePrescient Medicine is delivering the tools that define the precision healthcare movement—the future of medicine. We believe that with deeper predictive insights, tomorrow's researchers and caregivers can make better decisions, leading to the best possible patient outcomes. Through our expertise in pharmacology, chemistry, in vitro diagnostics (IVD), pathology, pharmacogenomics, and toxicology, we've created powerful tests and analytics that deliver the advanced test results and methodologies that help physicians and our partners make the right choice at the right time. Prescient has locations in Pennsylvania and Missouri and will open a Florida location later this year. Visit us at www.prescientmedicine.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/centerpointe-hospital-selects-prescient-medicine-as-preferred-laboratory-300416362.html
SOURCE Prescient Medicine
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All